GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » Asset Turnover

Ablynx NV (XBRU:ABLXS) Asset Turnover : 0.07 (As of Dec. 2017)


View and export this data going back to . Start your Free Trial

What is Ablynx NV Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Ablynx NV's Revenue for the six months ended in Dec. 2017 was €20.90 Mil. Ablynx NV's Total Assets for the quarter that ended in Dec. 2017 was €312.54 Mil. Therefore, Ablynx NV's Asset Turnover for the quarter that ended in Dec. 2017 was 0.07.

Asset Turnover is linked to ROE % through Du Pont Formula. Ablynx NV's annualized ROE % for the quarter that ended in Dec. 2017 was -127.87%. It is also linked to ROA % through Du Pont Formula. Ablynx NV's annualized ROA % for the quarter that ended in Dec. 2017 was -53.25%.


Ablynx NV Asset Turnover Historical Data

The historical data trend for Ablynx NV's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ablynx NV Asset Turnover Chart

Ablynx NV Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.22 0.31 0.32 0.17

Ablynx NV Semi-Annual Data
Dec07 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.18 0.11 0.14 0.07

Competitive Comparison of Ablynx NV's Asset Turnover

For the Biotechnology subindustry, Ablynx NV's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ablynx NV's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ablynx NV's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Ablynx NV's Asset Turnover falls into.



Ablynx NV Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Ablynx NV's Asset Turnover for the fiscal year that ended in Dec. 2017 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2017 )/( (Total Assets (A: Dec. 2016 )+Total Assets (A: Dec. 2017 ))/ count )
=55.562/( (266.764+389.848)/ 2 )
=55.562/328.306
=0.17

Ablynx NV's Asset Turnover for the quarter that ended in Dec. 2017 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2017 )/( (Total Assets (Q: Jun. 2017 )+Total Assets (Q: Dec. 2017 ))/ count )
=20.897/( (235.24+389.848)/ 2 )
=20.897/312.544
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Ablynx NV  (XBRU:ABLXS) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Ablynx NV's annulized ROE % for the quarter that ended in Dec. 2017 is

ROE %**(Q: Dec. 2017 )
=Net Income/Total Stockholders Equity
=-166.416/130.144
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-166.416 / 41.794)*(41.794 / 312.544)*(312.544/ 130.144)
=Net Margin %*Asset Turnover*Equity Multiplier
=-398.18 %*0.1337*2.4015
=ROA %*Equity Multiplier
=-53.25 %*2.4015
=-127.87 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2017) net income data. The Revenue data used here is two times the semi-annual (Dec. 2017) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Ablynx NV's annulized ROA % for the quarter that ended in Dec. 2017 is

ROA %(Q: Dec. 2017 )
=Net Income/Total Assets
=-166.416/312.544
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-166.416 / 41.794)*(41.794 / 312.544)
=Net Margin %*Asset Turnover
=-398.18 %*0.1337
=-53.25 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2017) net income data. The Revenue data used here is two times the semi-annual (Dec. 2017) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Ablynx NV Asset Turnover Related Terms

Thank you for viewing the detailed overview of Ablynx NV's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Ablynx NV (XBRU:ABLXS) Business Description

Traded in Other Exchanges
N/A
Address
Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV (XBRU:ABLXS) Headlines

No Headlines